NAD+ IV Therapy in NYC

NAD+ IV therapy is not a miracle treatment, but it is a real intervention with a real mechanism. NAD+, short for nicotinamide adenine dinucleotide, is a coenzyme central to cellular energy metabolism, mitochondrial function, and DNA repair signaling. Levels tend to fall with age and with metabolic stress. IV delivery can reach plasma concentrations oral supplementation cannot reliably match. At Liondale, NAD+ is offered as part of a physician-directed longevity plan, most often between therapeutic plasma exchange sessions or as a lower-cost starting point for patients who are not yet ready for plasma exchange. The evidence is not as deep as TPE. The mechanism is still credible. And for the right patient, it can be useful.

If you are searching for NAD+ infusion Manhattan, NAD+ IV drip New York, or nicotinamide adenine dinucleotide therapy NYC, the real question is where this therapy fits. NAD+ is usually not the anchor treatment for a patient with heavy inflammatory burden. It can be a smart support treatment, a recovery tool, or an entry point. My job is to place it correctly. If you want the broader framework first, read our concierge longevity medicine NYC guide or the main concierge care page. If you are weighing it directly against more aggressive interventions, our comparison guide to TPE and other treatments lays that out clearly.

What NAD+ Actually Does

NAD+ is a coenzyme involved in oxidative phosphorylation, the electron transport chain, and sirtuin activation. That sounds technical because it is. The plain-English version is simpler: NAD+ helps cells convert fuel into usable energy, and it sits inside several pathways tied to repair, resilience, and response to stress.

Sirtuins are NAD+-dependent enzymes involved in DNA repair, gene expression regulation, and cellular stress response. They are sometimes called longevity genes. That phrase is simplified, but not completely wrong. NAD+ also interacts with enzymes such as PARPs, which are involved in DNA damage signaling and repair. When NAD+ availability drops, cells do not stop working overnight, but energy production and recovery capacity can look less efficient over time. Patients rarely say it that way, of course. They say they feel flatter, less sharp, slower to recover, or older than they did a few years ago.

Levels decline with age, with poor metabolic health, and with chronic stress. Illness can do it too. So can poor sleep, alcohol excess, and the constant low-grade strain that many New Yorkers treat as normal. This is where IV delivery matters. Oral products have to make it through digestion, first-pass metabolism, and variable absorption. Many oral products are also precursors rather than NAD+ itself. IV administration bypasses those limits and achieves a higher circulating exposure, which is why the treatment feels different from buying a supplement bottle online.

That does not mean more is always better. It means route matters, dose matters, and pacing matters. When I use NAD+ in practice, I think about it as a metabolic support tool with a defined role, not a fountain-of-youth promise dressed up in a drip bag.

What the Evidence Shows - And Where It Stops

The strongest part of the NAD+ story is the mechanism. Cell and animal data are strong. Researchers have repeatedly shown that raising NAD+ availability can improve mitochondrial function, affect metabolic pathways, and influence stress-response systems that matter in aging biology. That is why NAD+ has remained interesting for more than a decade. The mechanism holds up under scrutiny.

The human data is more mixed, which is where honest framing matters. There are human studies showing that NAD+ biology can be influenced in ways that support metabolic function, energy pathways, and, in some settings, cognitive performance or fatigue-related complaints. But the literature is not one clean block of evidence, and much of it involves NAD+ precursors rather than IV NAD+ itself. So when patients ask whether the human data is solid, my answer is yes in parts, no in others, and not yet at the level many marketing pages imply.

This is the cleanest way to say it. NAD+ does not have a large randomized controlled trial equivalent to the 2025 Fuentealba TPE study for biological age reduction. TPE has that trial. NAD+ does not. That does not make NAD+ useless. It puts it in a different category. TPE is the stronger evidence-based intervention when the goal is a higher-level longevity procedure with published human trial data behind it. NAD+ is the more modest tool. Lower acuity. Lower cost. Easier entry. Different purpose.

Where do I think NAD+ is strongest? Energy support. Recovery between more intensive treatments. Metabolic support for the patient who feels run down, cognitively dulled, or slow to rebound, but who does not clearly need plasma exchange. The safety picture in real-world clinical use is familiar, and the main issue is infusion tolerance rather than hidden toxicity. But I do not tell patients this therapy is proven to reduce biological age in the way TPE has been studied. That would be overstating the case. There is enough here to use NAD+ intelligently. There is not enough to oversell it.

What to Expect During a Session

A typical session runs about 1.5 to 3 hours depending on dose and tolerance. This is an IV infusion, but it should not be treated like a standard hydration drip where speed is the goal. Higher-dose NAD+ infusions often need to run slowly. If the rate is pushed too fast, patients can feel flushing, chest tightness, nausea, abdominal discomfort, or a strange pressure sensation that is more unsettling than dangerous. Slow the rate down and those symptoms usually settle. Simple.

That rate management matters more than most people realize. Patients who had NAD+ elsewhere and thought they "couldn't tolerate it" often did not have a true problem with NAD+ itself. They had a problem with how fast it was pushed. When the infusion is paced correctly, the experience is usually much smoother. You sit comfortably, read, answer email, or rest. Some patients feel a wave of warmth or mild heaviness during the infusion. Others feel almost nothing until later.

Results are usually noticed in the hours to days after treatment, not in the first ten minutes. Many patients describe better mental clarity, steadier energy, or a cleaner sense of recovery over the next day or two. Not everyone feels a dramatic shift. Some do. That variability is normal, and it is one reason I care more about pattern over time than about whether a patient had a cinematic reaction after one drip.

Who Benefits Most at Liondale

The most common Liondale use case is the patient who is already doing TPE and wants support between sessions. That patient is not asking NAD+ to replace plasma exchange. They are using it to support recovery, energy, and momentum in the weeks between treatments. It fits well there.

The second strong profile is the patient who wants a lower-cost starting point before committing to plasma exchange. If the main complaint is reduced energy, cognitive fatigue, or slower recovery, and the inflammatory picture does not clearly justify TPE, NAD+ is a reasonable first move. Not always the final move. Sometimes just the first.

Another good fit is the patient in metabolic recovery after illness, overtraining, travel, sleep disruption, or prolonged work stress. Manhattan patients rarely present with one clean issue. They usually come in with a stack: poor sleep, high cognitive load, inconsistent recovery, and the sense that the margin they used to have is gone. NAD+ can be useful in that group because the complaint is often about resilience, not about one dramatic diagnosis.

Who is not a great fit? Patients expecting NAD+ to do what TPE does. Different mechanism. Different evidence depth. Different clinical indication. If someone needs a stronger intervention aimed at inflammatory burden or wants the treatment with the best current longevity trial data behind it, I tell them that directly and point them back to our TPE program. And if they want the blunt comparison, the page at /blog/tpe-vs-other-treatments/ covers that without pretending the two therapies are interchangeable.

How NAD+ Fits Into a Broader Protocol

Most Liondale patients who do TPE use NAD+ between sessions. A common pattern is TPE every 4-8 weeks as the anchor, NAD+ monthly or weekly for energy and recovery support, and medical ozone therapy added when inflammation, oxidative stress, or immune issues are part of the picture. That is a pattern, not a package. The sequence changes with labs, symptoms, travel schedule, and response.

Some patients start with NAD+ and add TPE later. That path makes sense when the complaint is fatigue or cognitive drag, the patient wants something physician-directed but not overly aggressive, and the baseline does not yet justify apheresis-level treatment. Other patients arrive because they already know they want TPE, then add NAD+ for the off-weeks because they do better when recovery support is built in. Both paths are valid. Neither should be sold as the default.

This is also where a physician-led program matters. A retail drip model tends to treat every infusion as a separate event. Real longevity care does not work like that. NAD+, TPE, hormone work, ozone, regenerative options, and general concierge oversight all affect the same patient. One therapy changes the context for the next. Which is why patients who want the whole Liondale framework should look at our concierge program and the fuller concierge longevity medicine overview before deciding how deep they want to go.

The Liondale Approach

This is not a drip bar. Dose and frequency are clinically determined after Dr. Bissoon reviews your goals, history, medications, and available labs. If something feels off during the infusion, the rate is adjusted or the session is modified. That sounds basic. It is also the difference between medical oversight and retail wellness.

I use NAD+ for defined indications. Usually that means recovery support between TPE sessions, help for the patient whose primary complaint is low energy and mental fatigue, or a more accessible first step before moving into a higher-ticket intervention. I do not present it as a catch-all anti-aging solution because it is not one. Good medicine starts by placing the treatment in the right lane.

Patients also benefit from continuity. The same physician who discusses NAD+ with you may also be guiding TPE timing, ozone therapy, hormone strategy, or the broader concierge plan. One practice. One medical record. One doctor who sees the whole picture. That is why Liondale works well for patients who want longevity care without bouncing between separate clinics that never compare notes.

If you want to know whether NAD+ belongs in your plan, the next step is a consultation, not guesswork. Contact Liondale Medical and we can decide whether this is the right entry point, a support treatment between TPE sessions, or something to skip for now.

FAQ

How is NAD+ IV different from oral NAD+ supplements?

IV NAD+ bypasses digestion and first-pass metabolism, so it can achieve circulating levels oral products cannot reliably match. Oral products are also often precursors rather than NAD+ itself. That does not make oral supplementation pointless, but it is a different tool. Patients usually notice the difference in how direct the IV treatment feels.

How often should I do NAD+ IV therapy?

It depends on why you are doing it. Some Liondale patients use it weekly for a short stretch, while others come monthly between TPE sessions or during periods of high stress and recovery demand. Frequency is based on goals, tolerance, and how the rest of the protocol is structured. There is no serious reason to force every patient into the same calendar.

Can I combine NAD+ with TPE?

Yes, and that is one of the most common use cases at Liondale. NAD+ is often used between TPE sessions to support recovery and energy. Timing matters, though. We plan around hydration, treatment spacing, labs, and how you actually felt after the last session rather than stacking therapies casually.

What does a session feel like?

Most patients sit comfortably for 1.5 to 3 hours while the infusion runs slowly. If the rate is too fast, you may feel flushing, chest tightness, nausea, or abdominal discomfort. When the rate is adjusted, those symptoms usually improve. Some patients feel warmer or slightly tired during the session, then clearer afterward.

How quickly will I notice results?

Some patients feel a shift the same day, but most notice the effect over the next 24-48 hours. The usual report is better mental clarity, steadier energy, or improved recovery. Not everyone feels a dramatic change after one infusion, which is why response is judged over time, not by one post-treatment story.

Is NAD+ IV safe?

For properly selected patients, the practical safety issue is usually infusion tolerance rather than a serious adverse event pattern. The most common problems are rate-related discomfort such as nausea, flushing, chest tightness, or cramping. That is why physician oversight and infusion pacing matter. Your medical history still needs review before treatment, especially if you have active illness, unstable symptoms, or other therapies that may affect the plan.

How does NAD+ compare to TPE in terms of evidence?

TPE has the stronger human evidence for longevity-focused use because it has a 2025 randomized controlled trial showing measurable biological age changes. NAD+ has credible mechanistic support and useful human data in narrower areas, but not an equivalent trial for biological age reduction. So the comparison is not close on evidence depth. NAD+ still has a role. It is just a different role.

This page was written and reviewed by Lionel Bissoon, D.O., founder of Liondale Medical. Dr. Bissoon is a board-certified osteopathic physician specializing in anti-aging and concierge medicine on the Upper West Side of Manhattan.

This content is for educational purposes only and does not constitute medical advice. Individual results may vary. Consult a qualified physician before beginning any new treatment.